Janet W. Maynard

Diuretic use, increased serum urate levels, and risk of incident gout in a population‐based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study

Mara McAdams‐DeMarco, Janet W. Maynard, Alan N. Baer et al. · Arthritis & Rheumatism · 2011 · 120 citations · Full text

Public Health, Chronic Disease Prevention, Community Health +12

Reliability and Sensitivity of the Self-report of Physician-diagnosed Gout in the Campaign Against Cancer and Heart Disease and the Atherosclerosis Risk in the Community Cohorts

Mara McAdams‐DeMarco, Janet W. Maynard, Alan N. Baer et al. · The Journal of Rheumatology · 2010 · 109 citations · Full text

Medicine, Community Health, Preventive Medicine +13

Secondary Sjögren’s Syndrome in Systemic Lupus Erythematosus Defines a Distinct Disease Subset

Alan N. Baer, Janet W. Maynard, FASIL SHAIKH et al. · The Journal of Rheumatology · 2010 · 94 citations · Full text

Medicine, Immunology, Autoimmunity +12

Using four decades of FDA orphan drug designations to describe trends in rare disease drug development: substantial growth seen in development of drugs for rare oncologic, neurologic, and pediatric-onset diseases

Kathleen L. Miller, Lewis J. Fermaglich, Janet W. Maynard · Orphanet Journal of Rare Diseases · 2021 · 93 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +16

Temporal Relationship Between Uric Acid Concentration and Risk of Diabetes in a Community-based Study Population

Stephen P. Juraschek, Mara McAdams‐DeMarco, Edgar R. Miller et al. · American Journal of Epidemiology · 2014 · 88 citations · Full text

Medicine, Health Sciences, Epidemiologic Methods +12